Indication
Staphylococcus aureus endocarditis
*Staphylococcus aureus* endocarditis is a severe, acute microbial infection of the endocardial surface of the heart, most frequently targeting the native or prosthetic cardiac valves. Read more about Staphylococcus aureus endocarditis
107 drugs 58 manufacturers
Drugs that treat it
Common Staphylococcus aureus endocarditis therapies.
CEFAZOLIN SODIUM
VANCOMYCIN HCL
CEFAZOLIN SODIUM
NAFCILLIN SODIUM
OXACILLIN SODIUM
VANCOMYCIN HCL
NAFCILLIN SODIUM
VANCOMYCIN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Staphylococcus aureus* endocarditis is a severe, acute microbial infection of the endocardial surface of the heart, most frequently targeting the native or prosthetic cardiac valves.
The condition primarily impacts the cardiovascular system, commonly affecting populations with intravascular catheters, prosthetic heart valves, underlying structural heart disease, or histories of injection drug use.
Pathophysiologically, the virulence of *Staphylococcus aureus* allows it to adhere to both injured and intact valvular endothelium, driving rapid tissue destruction, vegetation formation, and localized intracardiac abscesses.
This aggressive process carries substantial morbidity and mortality, clinically characterized by high fevers, acute valvular regurgitation leading to heart failure, persistent bacteremia, and a heightened risk of systemic septic embolization.
- nih.gov
*Staphylococcus aureus* endocarditis is a severe, acute microbial infection of the endocardial surface of the heart, most frequently targeting the native or prosthetic cardiac valves This aggressive process carries substantial morbidity and mortality, clinically characterized by high fevers, acute valvular regurgitation leading to heart failure, persistent bacteremia, and a heightened risk of systemic septic embolization
- nih.gov
*Staphylococcus aureus* endocarditis is a severe, acute microbial infection of the endocardial surface of the heart, most frequently targeting the native or prosthetic cardiac valves The condition primarily impacts the cardiovascular system, commonly affecting populations with intravascular catheters, prosthetic heart valves, underlying structural heart disease, or histories of injection drug use
- nih.gov
*Staphylococcus aureus* endocarditis is a severe, acute microbial infection of the endocardial surface of the heart, most frequently targeting the native or prosthetic cardiac valves Pathophysiologically, the virulence of *Staphylococcus aureus* allows it to adhere to both injured and intact valvular endothelium, driving rapid tissue destruction, vegetation formation, and localized intracardiac abscesses
- nih.gov
The condition primarily impacts the cardiovascular system, commonly affecting populations with intravascular catheters, prosthetic heart valves, underlying structural heart disease, or histories of injection drug use
- nih.gov
The condition primarily impacts the cardiovascular system, commonly affecting populations with intravascular catheters, prosthetic heart valves, underlying structural heart disease, or histories of injection drug use This aggressive process carries substantial morbidity and mortality, clinically characterized by high fevers, acute valvular regurgitation leading to heart failure, persistent bacteremia, and a heightened risk of systemic septic embolization
- nih.gov
Pathophysiologically, the virulence of *Staphylococcus aureus* allows it to adhere to both injured and intact valvular endothelium, driving rapid tissue destruction, vegetation formation, and localized intracardiac abscesses
- nih.gov
Pathophysiologically, the virulence of *Staphylococcus aureus* allows it to adhere to both injured and intact valvular endothelium, driving rapid tissue destruction, vegetation formation, and localized intracardiac abscesses This aggressive process carries substantial morbidity and mortality, clinically characterized by high fevers, acute valvular regurgitation leading to heart failure, persistent bacteremia, and a heightened risk of systemic septic embolization
Personalize your experience
Follow Staphylococcus aureus endocarditis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.